Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study


Bayoglu I. V. , Yildiz İ. , Varol U., Cokmert S., Alacacioglu A., Kucukzeybek Y., et al.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, cilt.19, ss.385-390, 2015 (ESCI İndekslerine Giren Dergi)

  • Cilt numarası: 19 Konu: 5
  • Basım Tarihi: 2015
  • Doi Numarası: 10.5114/wo.2015.53374
  • Dergi Adı: WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
  • Sayfa Sayısı: ss.385-390

Özet

Aim of the study: Our aim was to determine the activity and toxicity of uracil/tegafur and leucovorin combination in metastatic colorectal cancer (mCRC) patients who have progressed with all currently active agents.